Méniére's disease: subjective and objective evaluation of medical treatment with betahistine HCl.
D000161:Acoustic Stimulation; D000328:Adult; D000368:Aged; D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors*; D001299:Audiometry; D001621:Betahistine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005021:Ethylamines / Q000627:therapeutic use*; D005133:Eye Movements; D005260:Female; D005500:Follow-Up Studies; D006320:Hearing Tests; D006358:Hot Temperature; D006801:Humans; D008297:Male; D008575:Meniere Disease / Q000188:drug therapy*; D008875:Middle Aged; D010919:Placebos; D011725:Pyridines / Q000627:therapeutic use*; D012399:Rotation; D013268:Stimulation, Chemical
D005021:Ethylamines; D010919:Placebos; D011725:Pyridines; D006631:Amine Oxidase (Copper-Containing); D001621:Betahistine